Neurocrine Biosciences Inc. (NBIX) on GreekSoup https://greeksoup.ai/stocks/us/nbix/ Every dated entry in the public record on Neurocrine Biosciences Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 09 Oct 2026 00:00:00 +0000 Neurocrine Biosciences Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/nbix/filings/us:NBIX:filing:2026-09-28:e58e2beee6Mon, 28 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: Boyer David W. (Chief Corp. Affairs Officer) sold 826 shares at $157.45 on 14 September 2026, $130,051https://greeksoup.ai/stocks/us/nbix/insiders/us:NBIX:insider:2026-09-15:7db3da0cb3Tue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: Abernethy Matt (Chief Financial Officer) sold 2,311 shares at $157.20 on 14 September 2026, $363,285https://greeksoup.ai/stocks/us/nbix/insiders/us:NBIX:insider:2026-09-15:6015af606dTue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: short interest 4,964,907 shares at the 15 September 2026 settlement, 5.37 days to coverhttps://greeksoup.ai/stocks/us/nbix/short-interest/us:NBIX:short-interest:2026-09-15:294428e917Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: Form 144, MATTHEW C ABERNETHY plans to sell 2,311 shares worth $361,024 around 14 September 2026https://greeksoup.ai/stocks/us/nbix/planned-sales/us:NBIX:planned-sale:2026-09-14:5d9ae40765Mon, 14 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: Form 144, DAVID WARREN BOYER plans to sell 4,714 shares worth $736,421 around 14 September 2026https://greeksoup.ai/stocks/us/nbix/planned-sales/us:NBIX:planned-sale:2026-09-14:e183561d85Mon, 14 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: Benevich Eric (Chief Commercial Officer) sold 2,154 shares at $154.61 on 9 September 2026, $333,030https://greeksoup.ai/stocks/us/nbix/insiders/us:NBIX:insider:2026-09-10:1d864ca387Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: Form 144, ERIC BENEVICH plans to sell 2,154 shares worth $334,150 around 9 September 2026https://greeksoup.ai/stocks/us/nbix/planned-sales/us:NBIX:planned-sale:2026-09-09:fb5690b42bWed, 09 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: short interest 5,056,144 shares at the 31 August 2026 settlement, 4.65 days to coverhttps://greeksoup.ai/stocks/us/nbix/short-interest/us:NBIX:short-interest:2026-08-31:a8125d1b93Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: short interest 4,551,075 shares at the 14 August 2026 settlement, 3.42 days to coverhttps://greeksoup.ai/stocks/us/nbix/short-interest/us:NBIX:short-interest:2026-08-14:b84f4e16e8Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc. Q2 FY2026 results: revenue $959 million, net income $144 millionhttps://greeksoup.ai/stocks/us/nbix/results/fy2026-q2/us:NBIX:result:2026-07-31:7aac038ab4Fri, 31 Jul 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc. filed 8-K/A: 8-k/ahttps://greeksoup.ai/stocks/us/nbix/filings/us:NBIX:filing:2026-07-31:c3b028bb74Fri, 31 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc. filed S-8: s-8https://greeksoup.ai/stocks/us/nbix/filings/us:NBIX:filing:2026-07-31:220c0947ddFri, 31 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/nbix/filings/us:NBIX:filing:2026-07-31:9f510fa373Fri, 31 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: short interest 4,390,083 shares at the 31 July 2026 settlement, 3.01 days to coverhttps://greeksoup.ai/stocks/us/nbix/short-interest/us:NBIX:short-interest:2026-07-31:d19c5a3212Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/nbix/filings/us:NBIX:filing:2026-07-30:1d1c2b655fThu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: Norwalk Leslie V (Director) sold 1,250 shares at $182.01 on 28 July 2026, $227,508https://greeksoup.ai/stocks/us/nbix/insiders/us:NBIX:insider:2026-07-30:776251b4eeThu, 30 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: Schedule 13G/A filed by JPMORGAN CHASE & CO., 6.3% of the classhttps://greeksoup.ai/stocks/us/nbix/holders/us:NBIX:schedule-13:2026-07-27:b2769c8a26Mon, 27 Jul 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: short interest 5,334,688 shares at the 15 July 2026 settlement, 4.91 days to coverhttps://greeksoup.ai/stocks/us/nbix/short-interest/us:NBIX:short-interest:2026-07-15:4aba2cffffWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: Delaet Ingrid (Chief Regulatory Officer) sold 4,367 shares at $181.02 on 10 July 2026, $790,514https://greeksoup.ai/stocks/us/nbix/insiders/us:NBIX:insider:2026-07-13:cc10a64982Mon, 13 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Neurocrine Biosciences Inc.: Lippoldt Darin (Chief Legal Officer) sold 10,000 shares at $179.60 on 9 July 2026, $1.8 millionhttps://greeksoup.ai/stocks/us/nbix/insiders/us:NBIX:insider:2026-07-13:64cbdf7312Mon, 13 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]>